/C O R R E C T I O N -- ALZpath, Inc./
In the news release, ALZpath and Quanterix Expand Strategic Licensing Agreement to Advance Next Generation Alzheimer's Disease Biomarker Research, issued 07-Oct-2026 by ALZpath, Inc. over PR Newswire, we are advised by the company that the sub-headline has been revised. The complete,...
Covered in this story
Call it yourself
No calls on $QTRX yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Quanterix Corp →Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.